About 1 result found for searched term "2134641-34-0" (0.128 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M31386 | Epcoritamab | CD20 |
| Epcoritamab is a novel bispecific IgG1k/λ antibody targeting CD3 and CD20 that activates T cells and directs them to kill malignant CD20+ B cells.Epcoritamab has antitumor activity and may be used in studies related to RR diffuse large B-cell lymphoma (DLBCL). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
